Toludevenlafaxine hydrochloride sustained-release tablets

toludevenlafaxine hydrochloride · Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Toludevenlafaxine hydrochloride sustained-release tablets, covering 2024-05-23 to 2024-05-23. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets [Phase 4]

See pricing